{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:11:35Z","timestamp":1792987895842,"version":"4.5.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["15SFDRN25080331"],"award-info":[{"award-number":["15SFDRN25080331"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"crossref","award":["UL1TR003096"],"award-info":[{"award-number":["UL1TR003096"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["P30DK079626 and P30DK056336"],"award-info":[{"award-number":["P30DK079626 and P30DK056336"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K24DK116180"],"award-info":[{"award-number":["K24DK116180"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Lowering phosphorus additive intake reduces fibroblast growth factor 23 concentrations in adults with and without CKD.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Lowering phosphorus additive intake reduced fibroblast growth factor 23 in White but not in Black healthy individuals.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Lowering phosphorus additive intake reduces circulating parathyroid hormone concentrations in individuals with CKD.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Excess phosphorus additive intake leads to alterations in phosphorus metabolism that are linked to cardiovascular and kidney disease. The effects of lowering phosphorus additive intake in adults with and without CKD are unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a feeding study in 39 adults without and 11 adults with CKD. Participants were fed a phosphorus additive-enhanced diet for 2 weeks followed by a low additive diet for 6 weeks. Both diets were identical except for phosphorus additive content. Blood and urine samples were collected at regular intervals with analyses comparing follow-up measures of mineral metabolism markers to baseline values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean (SD) age of the non-CKD group was 34 (12) years, among whom 51% were male, 36% were of Black race, and the mean (SD) eGFR was 106 (16) ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      . The mean (SD) age of the CKD group was 72 (6) years, among whom 36% were male, 82% were of Black race, and the mean (SD) eGFR was 35 (13) ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      . After consuming the additive-enhanced diet for 2 weeks, consuming the low additive diet for 6 weeks decreased 24-hour urine phosphorus excretion by approximately 30% in both groups. In the non-CKD group, the effect of the low additive diet on circulating fibroblast growth factor 23 (FGF23) concentrations differed by race (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>interaction<\/jats:sub>\n                      = 0.03)\u2014FGF23 decreased by 22% from baseline in White adults (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) but not in Black adults (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.08). In the CKD group, FGF23 decreased 25% after 6 weeks of the low additive diet (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) with no difference by race. Intact parathyroid hormone concentrations decreased 20% in CKD participants and did not change in the non-CKD participants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Six weeks of a low phosphorus additive diet decreased FGF23 and parathyroid hormone in adults with moderate CKD. Lowering phosphorus additive intake lowered FGF23 in White adults without CKD but had no effect in Black adults without CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial registry name and registration number:<\/jats:title>\n                    <jats:p>NCT02620449.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000000730","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:01:10Z","timestamp":1747155670000},"page":"950-957","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Effects of Lowering Dietary Phosphorus Additive Intake on Mineral Metabolism in Adults with and without CKD"],"prefix":"10.2215","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0546-8975","authenticated-orcid":false,"given":"Muhammad Bilal","family":"Khan","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Marnix Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7035-0848","authenticated-orcid":false,"given":"Mercedes R.","family":"Carnethon","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9763-2367","authenticated-orcid":false,"given":"Tamara","family":"Isakova","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine and Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1127-1442","authenticated-orcid":false,"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6593-3571","authenticated-orcid":false,"given":"Orlando M.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Marnix Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"6","key":"B2-20250919","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3945\/an.113.004812","article-title":"The connection between dietary phosphorus, cardiovascular disease, and mortality: where we stand and what we need to know","volume":"4","author":"Guti\u00e9rrez","year":"2013","journal-title":"Adv Nutr."},{"issue":"1","key":"B3-20250919","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/j.jrn.2013.09.003","article-title":"Contribution of food additives to sodium and phosphorus content of diets rich in processed foods","volume":"24","author":"Carrigan","year":"2014","journal-title":"J Ren Nutr."},{"issue":"1","key":"B4-20250919","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41581-019-0189-5","article-title":"FGF23 at the crossroads of phosphate, iron economy and erythropoiesis","volume":"16","author":"Edmonston","year":"2020","journal-title":"Nat Rev Nephrol."},{"issue":"11","key":"B5-20250919","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1210\/jc.2015-2279","article-title":"Impact of phosphorus-based food additives on bone and mineral metabolism","volume":"100","author":"Guti\u00e9rrez","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B6-20250919","doi-asserted-by":"crossref","first-page":"108374","DOI":"10.1016\/j.jnutbio.2020.108374","article-title":"Effects of phosphorus and calcium to phosphorus consumption ratio on mineral metabolism and cardiometabolic health","volume":"80","author":"Guti\u00e9rrez","year":"2020","journal-title":"J Nutr Biochem."},{"issue":"12","key":"B7-20250919","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1093\/ndt\/gfq316","article-title":"Racial differences in postprandial mineral ion handling in health and in chronic kidney disease","volume":"25","author":"Guti\u00e9rrez","year":"2010","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"B9-20250919","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcn\/51.2.241","article-title":"A new predictive equation for resting energy expenditure in healthy individuals","volume":"51","author":"Mifflin","year":"1990","journal-title":"Am J Clin Nutr."},{"issue":"1","key":"B10-20250919","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl (2011)."},{"issue":"2","key":"B11-20250919","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.ajkd.2016.08.029","article-title":"Phosphorus additives and albuminuria in early stages of CKD: a randomized controlled trial","volume":"69","author":"Chang","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B12-20250919","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/ndt\/gfs405","article-title":"Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial","volume":"28","author":"Sigrist","year":"2013","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B13-20250919","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3945\/ajcn.114.085498","article-title":"Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study","volume":"100","author":"Ix","year":"2014","journal-title":"Am J Clin Nutr."},{"issue":"8","key":"B14-20250919","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J Bone Miner Res."},{"issue":"8","key":"B15-20250919","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2008.4","article-title":"Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease","volume":"73","author":"Guti\u00e9rrez","year":"2008","journal-title":"Kidney Int."},{"issue":"4","key":"B16-20250919","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2215\/CJN.08020715","article-title":"Genetic African ancestry and markers of mineral metabolism in CKD","volume":"11","author":"Guti\u00e9rrez","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"B17-20250919","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/j.ackd.2014.05.005","article-title":"Contextual poverty, nutrition, and chronic kidney disease","volume":"22","author":"Guti\u00e9rrez","year":"2015","journal-title":"Adv Chronic Kidney Dis."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:36:53Z","timestamp":1786369013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000730","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"2024-12-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}